On 20 February 2026, Shandong Weigao Group Medical Polymer Company Limited (01066) disclosed the repurchase of 60,000 H shares on the Hong Kong Stock Exchange. This represented approximately 0.00% of its shares outstanding prior to the transaction, with the volume-weighted average repurchase price at HKD 5.11 and an aggregate consideration of HKD 306,400.
Following the repurchase, the number of shares excluding treasury shares decreased from 4,480.87 million to 4,480.81 million, whereas treasury shares increased from 41.46 million to 41.52 million. The total number of issued shares remained at 4,522.33 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.